Immediate Impact
56 standout
Citing Papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Works of Hassal Lee being referenced
A molecular and preclinical comparison of the PD-1–targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Hassal Lee | 155 | 40 | 3 | 59 | 45 | 5 | 197 | |
| Kees Bisschop | 118 | 48 | 38 | 40 | 7 | 175 | ||
| Ziwen Yu | 185 | 59 | 102 | 45 | 4 | 235 | ||
| Keisuke Onoi | 113 | 23 | 41 | 71 | 5 | 155 | ||
| Blanca Navarro Rodrigo | 108 | 32 | 1 | 77 | 37 | 6 | 148 | |
| Zhehua Shao | 58 | 56 | 1 | 63 | 35 | 6 | 159 | |
| André Ly | 113 | 37 | 1 | 108 | 22 | 4 | 186 | |
| Veronica Pacetti | 150 | 22 | 101 | 15 | 4 | 222 | ||
| Mélanie Buchi | 132 | 66 | 90 | 30 | 6 | 215 | ||
| Gert Van den Eyden | 131 | 29 | 106 | 27 | 4 | 189 | ||
| Jacob Stultz | 70 | 60 | 52 | 61 | 5 | 215 |
All Works
Login with ORCID to disown or claim papers
Loading papers...